myotonic dystrophy

(redirected from myotonic muscular dystrophy)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to myotonic muscular dystrophy: myotonic dystrophy, Duchenne muscular dystrophy

myotonic dystrophy

[¦mī·ə¦tän·ik ′dis·trə·fē]
(medicine)
A hereditary disease, transmitted as an autosomal dominant, characterized by lack of normal relaxation of muscles after contraction, slowly progressive muscular weakness and atrophy, especially of the face and neck, cataract formation, early baldness, gonadal atrophy, abnormal glucose tolerance curve, and, frequently, mental deficiency.
Mentioned in ?
References in periodicals archive ?
Doctors sometimes prescribe phenytoin or quinine to help relax the muscles of people with myotonic muscular dystrophy.
Myotonic muscular dystrophy is caused when a portion of a particular gene is larger than it should be.
Provided the results of this confirmatory clinical trial replicate those of the ongoing, open-label, dose-escalation study, we believe we will be able to rapidly move IPLEX[TM] into Phase III development for Myotonic Muscular Dystrophy, an indication which we believe represents a significant market opportunity for the company.
Myotonic muscular dystrophy, also known as myotonic dystrophy, dystrophia myotonica or Steinert's disease, is the most common type of adult muscular dystrophy, affecting 1 in 8000 individuals (approximately 40,000 people in the United States).
IPLEX[TM] is currently being studied as a treatment for several serious medical conditions, Myotonic Muscular Dystrophy (MMD); Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease; HIV-Associated Adipose Redistribution Syndrome (HARS); and retinopathy of prematurity (ROP).